leadf
logo-loader
viewNovartis AG (ADR)

Sandoz 'pioneering' in the biosimilars space to help reduce the increasing cost of care

Sandoz Inc, a division of Novartis (NYSE:NVS), President of US and Head of North America Carol Lynch sat down with Proactive Investors at BIO CEO in New York. Carol spoke about hurdles the US market is facing in the biosimilars space. She leads the Sandoz US commercial and country organization, responsible for over 35% of the coompany's global revenue, and oversees commercial operations in Canada.

Quick facts: Novartis AG (ADR)

Price: 90.94 USD

NYSE:NVS
Market: NYSE
Market Cap: $208.16 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

AVZ Minerals strengthens financing discussions after boosting equity stake...

AVZ Minerals Ltd's (ASX:AVZ) Nigel Ferguson speaks to Proactive's Andrew Scott after announcing they've executed a share purchase agreement (SPP) to secure an additional 10% of Dathcom Mining SA from its JV partner, Dathomir Mining Resources SARLU, the 100% holder of the Manono Lithium and Tin...

55 minutes ago

2 min read